Prophylaxis of


Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
09 09 2019
Historique:
medline: 19 9 2019
entrez: 19 9 2019
pubmed: 19 9 2019
Statut: ppublish

Résumé

Globally, more people die annually from tuberculosis than from any other single infectious agent. Unfortunately, there is no commercially-available vaccine that is sufficiently effective at preventing acquisition of pulmonary tuberculosis in adults. In this study, pre-exposure prophylactic pulmonary delivery of active aerosolized anti-tuberculosis bacteriophage D29 was evaluated as an option for protection against

Identifiants

pubmed: 31527037
pii: AAC.00871-19
doi: 10.1128/AAC.00871-19
pmc: PMC6879268
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI125160
Pays : United States

Informations de copyright

Copyright © 2019 American Society for Microbiology.

Références

Tuberculosis (Edinb). 2012 Mar;92(2):160-5
pubmed: 22197183
MBio. 2015 Feb 17;6(1):e02537-14
pubmed: 25691598
J Aerosol Med Pulm Drug Deliv. 2013 Dec;26(6):317-35
pubmed: 23597003
Bacteriophage. 2011 Mar;1(2):111-114
pubmed: 22334867
Clin Microbiol Rev. 2019 Jan 16;32(2):
pubmed: 30651225
Viruses. 2018 Dec 25;11(1):
pubmed: 30585199
J Appl Microbiol. 2011 Jan;110(1):106-17
pubmed: 20875034
J Virol. 2015 Aug;89(16):8107-10
pubmed: 26018169
Bacteriophage. 2015 Apr 18;5(1):e1020260
pubmed: 26442188
Vaccine. 2015 Jun 12;33(26):3038-46
pubmed: 25869894
J Aerosol Med Pulm Drug Deliv. 2008 Dec;21(4):351-60
pubmed: 18800880
J Infect Public Health. 2012 Mar;5(1):67-81
pubmed: 22341846
CMAJ. 2013 Mar 5;185(4):287-8
pubmed: 23382256
Open Forum Infect Dis. 2017 Aug 29;4(3):ofx137
pubmed: 28875155
Virology. 2012 Dec 20;434(2):187-201
pubmed: 23084079
Inhal Toxicol. 2012 Jan;24(1):27-35
pubmed: 22145784
J Aerosol Med Pulm Drug Deliv. 2011 Oct;24(5):225-34
pubmed: 21671753
Vaccine. 2013 Sep 13;31(40):4322-9
pubmed: 23880366
Int J Pharm. 2017 Apr 15;521(1-2):141-149
pubmed: 28163231
J Appl Toxicol. 1998 Mar-Apr;18(2):149-60
pubmed: 9570698
Vaccines (Basel). 2018 May 24;6(2):null
pubmed: 29795025
J Aerosol Med Pulm Drug Deliv. 2014 Oct;27(5):315-28
pubmed: 24299502
Antimicrob Agents Chemother. 2014 Jul;58(7):4005-13
pubmed: 24798268
PLoS Pathog. 2014 Mar 20;10(3):e1003953
pubmed: 24651299
Mol Pharm. 2015 Aug 3;12(8):2688-96
pubmed: 25915006
Environ Health Perspect. 1976 Aug;16:17-24
pubmed: 1017420
Front Microbiol. 2016 Oct 24;7:1681
pubmed: 27822205
Am J Public Health Nations Health. 1954 Oct;44(10):1326-33
pubmed: 13197609
Tanaffos. 2017;16(2):149-156
pubmed: 29308080
N Engl J Med. 2018 Jul 12;379(2):138-149
pubmed: 29996082
Pharm Res. 2009 Nov;26(11):2401-16
pubmed: 20183916
J Aerosol Med Pulm Drug Deliv. 2016 Oct;29(5):393-405
pubmed: 26745146
PLoS Med. 2006 Dec;3(12):e494
pubmed: 17194191
Pharmacol Ther. 2017 Oct;178:141-147
pubmed: 28442326
Bacteriophage. 2011 Mar;1(2):66-85
pubmed: 22334863
Sci Transl Med. 2010 Oct 13;2(53):53ra74
pubmed: 20944089
Clin Vaccine Immunol. 2015 Dec 09;23(2):137-47
pubmed: 26656121
J Pharm Sci. 2003 May;92(5):1066-76
pubmed: 12712427
Clin Infect Dis. 2016 May 15;62 Suppl 3:S231-7
pubmed: 27118852
Am J Respir Crit Care Med. 2004 Jan 1;169(1):120-4
pubmed: 14512270
Antimicrob Agents Chemother. 2017 Sep 22;61(10):
pubmed: 28807909
Eur J Pharm Biopharm. 2018 Jun;127:213-222
pubmed: 29486303
Pharm Res. 2016 Jun;33(6):1486-96
pubmed: 26928668
BMJ. 2011 Sep 29;343:d5974
pubmed: 21964347
Exp Lung Res. 2014 Mar;40(2):86-98
pubmed: 24446702
Pharm Res. 2017 Oct;34(10):2084-2096
pubmed: 28646325
Appl Microbiol. 1972 Nov;24(5):812-8
pubmed: 4344961
Nat Med. 2019 May;25(5):730-733
pubmed: 31068712
Cell Host Microbe. 2017 Jul 12;22(1):38-47.e4
pubmed: 28704651
Int J Pharm. 2019 Jan 10;554:322-326
pubmed: 30445174
Front Cell Infect Microbiol. 2012 May 30;2:74
pubmed: 22919665
J Med Microbiol. 2011 Jun;60(Pt 6):699-709
pubmed: 21459912
J Pharm Sci. 2011 Dec;100(12):5197-205
pubmed: 22020816
Respir Physiol Neurobiol. 2004 Jun 25;140(3):283-91
pubmed: 15186789

Auteurs

Nicholas B Carrigy (NB)

Department of Mechanical Engineering, University of Alberta, Edmonton, Canada.

Sasha E Larsen (SE)

Infectious Disease Research Institute, Seattle, USA.

Valerie Reese (V)

Infectious Disease Research Institute, Seattle, USA.

Tiffany Pecor (T)

Infectious Disease Research Institute, Seattle, USA.

Melissa Harrison (M)

Department of Chemical and Materials Engineering, University of Alberta, Edmonton, Canada.

Philip J Kuehl (PJ)

Lovelace Biomedical, Albuquerque, USA.

Graham F Hatfull (GF)

Department of Biological Sciences, University of Pittsburgh, Pittsburgh, USA.

Dominic Sauvageau (D)

Department of Chemical and Materials Engineering, University of Alberta, Edmonton, Canada.

Susan L Baldwin (SL)

Infectious Disease Research Institute, Seattle, USA.

Warren H Finlay (WH)

Department of Mechanical Engineering, University of Alberta, Edmonton, Canada.

Rhea N Coler (RN)

Infectious Disease Research Institute, Seattle, USA.
Department of Global Health, University of Washington, Seattle, USA.
PAI Life Sciences Inc., Seattle, USA.

Reinhard Vehring (R)

Department of Mechanical Engineering, University of Alberta, Edmonton, Canada reinhard.vehring@ualberta.ca.

Classifications MeSH